A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy
Science Immunology · 14.08.2026 · 11 (122)
DOI: 10.1126/sciimmunol.adw6399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 14.08.2026. Verfasst von Adriana Loverre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, INSERM U932, Paris, France. Hauptthemen laut MEDLINE: Autophagy, Dendritic Cells, Immunotherapy, Neutrophils. Die Arbeit nennt 46 Literaturangaben. Gefördert von: H2020 European Research Council, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
The cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway promotes tumor immunogenicity, but intratumoral STING agonists, despite strong preclinical efficacy, have shown limited clinical efficacy. The mechanisms restricting therapeutic STING activation remain unclear. In mice, intratumoral delivery of the endogenous STING ligand cyclic guanosine monophosphate–adenosine monophosphate (GMP-AMP) (cGAMP) using viruslike particles (VLPs) preferentially activates STING in dendritic cells and primes circulating tumor-specific T cells. Using this system, we investigated mechanisms limiting effective STING-based immunotherapy. STING-induced type I interferon signaling was dispensable for cGAMP-VLP–mediated tumor control. In contrast, dendritic cell autophagy was required for generating circulating antitumor CD8 T cells and for regulating baseline neutrophil levels in lymph nodes. cGAMP-VLP overrode this regulation, inducing neutrophil accumulation in tumors and draining lymph nodes that limited efficacy. Neutrophil depletion enhanced tumor control through mechanisms involving neutrophil elastase and programmed cell death 1 ligand 1. These findings reveal that defective dendritic cell autophagy and neutrophil-mediated immunosuppression, rather than insufficient interferon signaling, hinder the effectiveness of intratumoral STING immunotherapy in preclinical mouse models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut Curie, PSL Research University, INSERM U932, Paris, France.
- Stimunity, Paris, France.
ORCID-Profile: Adriana Loverre, Bakhos Jneid, Magali Genest, Chantal Alkhoury, Konstantina Antoniadou, Nicolas Manel
Förderung
- H2020 European Research Council
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- Fondation ARC pour la Recherche sur le Cancer
- Cancéropôle Île-de-France
Zitieren
APA
Loverre, A., Jneid, B., Delisle, F., Genest, M., Alkhoury, C., Antoniadou, K., & Manel, N. (2026). A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy. Science Immunology, 11(122). https://doi.org/10.1126/sciimmunol.adw6399
Vancouver
Loverre A, Jneid B, Delisle F, Genest M, Alkhoury C, Antoniadou K, et al. A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy. Science Immunology. 2026;11(122). doi:10.1126/sciimmunol.adw6399
BibTeX
@article{Loverre2026,
author = {Loverre, Adriana and Jneid, Bakhos and Delisle, Fabien and Genest, Magali and Alkhoury, Chantal and Antoniadou, Konstantina and Manel, Nicolas},
title = {A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy},
journal = {Science Immunology},
year = {2026},
volume = {11},
number = {122},
doi = {10.1126/sciimmunol.adw6399}
}
EUVIMED